STALICLA’s In-Licensing Agreement with Novartis

Martina Bellini North America Legal Chronicle
Tagged:

Goodwin Procter advised STALICLA SA on the deal.STALICLA SA announced its exclusive in-licensing agreement with Novartis to develop mavoglurant as a treatment for substance-use disorder, neurodevelopmental disorders,…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:
Martina Bellini

Author: Martina Bellini

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here